Company intelligence / Profile preview

CancerTools.org

London, England, United Kingdomcancertools.org ↗

Ownership: Private
Employees: ~281
Development stage: Other

Overview

Provides access to an extensive portfolio of validated cancer research tools from over 175 institutes worldwide. These resources accelerate basic and translational oncology discoveries by enabling global sharing and distribution. Recent collaborations include making advanced NSCLC patient-derived xenograft models available to researchers.[8] No clinical results as it does not conduct clinical trials.

Therapeutic areas: Oncology
Modalities: AntibodyCell lineOrganoidSmall moleculeProteinVectorPDX model (patient-derived xenograft)Mouse modelCell culture media
Industry: Non-Drug Biotech

Partnerships

European Association for Cancer Research (EACR)UCLB/UCL Institute of Child Health for NSCLC PDX collaborationvarious academic institutions globally (>175 institutes)

Beyond the preview

Go deeper on CancerTools.org.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CancerTools.org.

Explore the full profile